MENU
+Compare
INCY
Stock ticker: NASDAQ
AS OF
Oct 17, 04:59 PM (EDT)
Price
$87.56
Change
+$0.25 (+0.29%)
Capitalization
17.05B

INCY Incyte Corp Forecast, Technical & Fundamental Analysis

Incyte focuses on the discovery and development of small-molecule drugs... Show more

Industry: #Biotechnology
INCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for INCY with price predictions
Oct 16, 2025

INCY saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for INCY moved out of overbought territory on October 09, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 64 similar instances where the indicator exited the overbought zone. In of the 64 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INCY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 29, 2025. You may want to consider a long position or call options on INCY as a result. In of 102 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for INCY just turned positive on October 15, 2025. Looking at past instances where INCY's MACD turned positive, the stock continued to rise in of 34 cases over the following month. The odds of a continued upward trend are .

INCY moved above its 50-day moving average on October 13, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INCY advanced for three days, in of 307 cases, the price rose further within the following month. The odds of a continued upward trend are .

INCY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INCY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.088) is normal, around the industry mean (24.427). P/E Ratio (20.641) is within average values for comparable stocks, (54.848). Projected Growth (PEG Ratio) (0.127) is also within normal values, averaging (2.179). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (3.792) is also within normal values, averaging (351.995).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INCY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
INCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

INCY is expected to report earnings to rise 1.91% to $1.60 per share on October 28

Incyte Corp INCY Stock Earnings Reports
Q3'25
Est.
$1.60
Q2'25
Beat
by $0.17
Q1'25
Beat
by $0.12
Q4'24
Missed
by $0.08
Q3'24
Beat
by $0.04
The last earnings report on July 29 showed earnings per share of $1.57, beating the estimate of $1.40. With 721.42K shares outstanding, the current market capitalization sits at 17.05B.
A.I. Advisor
published General Information

General Information

a developer of drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1801 Augustine Cut-Off
Phone
+1 302 498-6700
Employees
2524
Web
https://www.incyte.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BILD28.07N/A
N/A
Macquarie Global Listed Infras ETF
JUNP29.72-0.10
-0.34%
PGIM S&P 500 Buffer 12 ETF - Jun
FEUS71.61-0.45
-0.62%
FlexShares ESG & Clmt US Lrg Cap Cr Idx
AWP3.88-0.04
-0.90%
abrdn Global Premier Properties Fund
XOP123.29-2.64
-2.10%
SPDR® S&P Oil & Gas Explor & Prodtn ETF

INCY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, INCY has been loosely correlated with AGIO. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if INCY jumps, then AGIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INCY
1D Price
Change %
INCY100%
-0.95%
AGIO - INCY
39%
Loosely correlated
+0.34%
AXON - INCY
39%
Loosely correlated
+1.11%
RNAC - INCY
38%
Loosely correlated
-2.38%
TECH - INCY
38%
Loosely correlated
+3.39%
REGN - INCY
37%
Loosely correlated
-1.26%
More